Medical treatment of ovarian endometriomas: a prospective evaluation of the effect of dienogest on ovarian reserve, cyst diameter, and associated pain
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
The aim of the present study was to evaluate the effect of medical treatment of ovarian endometriomas on cyst diameter, associated pain, and ovarian reserve as measured with antral follicle count (AFC) and anti-Mullerian hormone (AMH). In this prospective study, 32 patients with unilateral endometrioma associated with pelvic pain, underwent 6-month medical treatment with dienogest. Before treatment, and at the end of 6 months of treatment, patients underwent evaluation of endometrioma diameter and AFC at transvaginal ultrasonography, measurement of AMH, and evaluation of associated pain. Mean cyst diameter was 4.0 ± 1.3 cm at baseline, and 2.4 ± 1.2 cm after 6 months of treatment (p < .0001), for a reduction in diameter of 40% and a reduction in volume of 79%. Mean visual analog scale score at enrollment was 6.3 ± 2.0, with a significant improvement at 6 months (0.9 ± 1.0, p < .0001). AFC for the affected ovary improved from 4.2 ± 2.8 at baseline, to 8.6 ± 4.2 cm after 6 months (+105%; p < .0001). AMH did not change significantly from baseline (3.40 ± 2.32 ng/mL) to end of treatment (2.80 ± 1.90 ng/mL, –18%, p = .27). Medical treatment with dienogest significantly reduces endometrioma diameter and associated pain, whereas the ovarian reserve appears to be preserved, with a significant improvement of AFC and no significant change in AMH.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“it causes a significant reduction in both diameter and volume of OMA, whereas the ovarian reserve appears to be preserved [190].”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [190]
Citations
Cites
ESHRE guideline: management of women with endometriosis
Dunselman, G. A. J., Vermeulen, N., Becker, C., Calhaz-Jorge, C., D'Hooghe, T., De Bie, B., Heikinheimo, O., Horne, A. W., Kiesel, L., Nap, A., et al. (2014) · Human Reproduction · doi:10.1093/humrep/det457 · Cited by 2,211
Endometriosis and infertility: a committee opinion
(2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.05.031 · Cited by 633
Raffi, F., Metwally, M., & Amer, S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1558 · Cited by 546 · cited 1×
“in 2012 reports a 34% decrease in postoperative AMH after laparoscopic excision of ovarian endometriomas [9].”
BackgroundOvarian reserve testing: a user’s guide
Tal, R., & Seifer, D. B. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.02.027 · Cited by 510 · cited 1×
“AMH is produced by preantral and small (<6mm) antral follicles, whereas AFC is defined as the number of larger antral follicles, between 2 and 10mm [17].”
BackgroundEndometriosis: Diagnosis and Management
Leyland, N., Casper, R., Laberge, P., Singh, S. S., Allen, L., Arendas, K., Leyland, N., Allaire, C., Awadalla, A., Best, C., et al. (2010) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)34589-3 · Cited by 427
Treatment of pelvic pain associated with endometriosis: a committee opinion
(2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.02.012 · Cited by 397
Management of ovarian endometriomas
Chapron, C. (2002) · Human Reproduction Update · doi:10.1093/humupd/8.6.591 · Cited by 244 · cited 1×
“in 17–44% of women with endometriosis [1].”
Muzii, L., Di Tucci, C., Di Feliciantonio, M., Galati, G., Di Donato, V., Musella, A., Palaia, I., & Panici, P. B. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.06.025 · Cited by 168
Self-citationEndometriotic ovarian cysts negatively affect the rate of spontaneous ovulation
Benaglia, L., Somigliana, E., Vercellini, P., Abbiati, A., Ragni, G., & Fedele, L. (2009) · Human Reproduction · doi:10.1093/humrep/dep202 · Cited by 148 · cited 1×
“5 cm at enrollment, since, in the presence of a larger cyst, AFC may be less reliable as a marker of ovarian reserve [12,13].”
BackgroundEndometrioma-related reduction in ovarian reserve (ERROR): a prospective longitudinal study
Kasapoglu, I., Ata, B., Uyaniklar, O., Seyhan, A., Orhan, A., Yildiz Oguz, S., & Uncu, G. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.03.015 · Cited by 146 · cited 2×
“Due to the present reassuring data on ovarian reserve under medical treatment, as opposed to a significant decrease in ovarian reserve reported with expectant management [11], medical treatment may be envisaged even in case of asymptomatic ovarian endometriomas, since it allows preservation of the ovarian reserve.”
Background
Research works printed but not linked: 3
- Muzii L, 2017, Semin Reprod Med, 35, 25
- Hart RJ, 2008, Cochrane Database Syst Rev, 16, CD004992
- Ersahin AA, 2017, Eur Rev Med Pharmacol Sci, 21, 2499
Cited by
Hormonal treatments for endometriosis: The endocrine background
Vannuccini, S., Clemenza, S., Rossi, M., & Petraglia, F. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09666-w · Cited by 336
Younis, J. S., Shapso, N., Ben-Sira, Y., Nelson, S. M., & Izhaki, I. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.06.102 · Cited by 105
A Lifelong Impact on Endometriosis: Pathophysiology and Pharmacological Treatment
Chen, L.-H., Lo, W.-C., Huang, H.-Y., & Wu, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087503 · Cited by 110
Hormonal drugs for the treatment of endometriosis
Capezzuoli, T., Rossi, M., Torre, F. L., Vannuccini, S., & Petraglia, F. (2022) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2022.102311 · Cited by 91
Muzii, L., Tucci, C. D., Galati, G., Carbone, F., Palaia, I., Bogani, G., Perniola, G., Tomao, F., Kontopantelis, E., & Donato, V. D. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01266-0 · Cited by 59
Self-citation
Metadata
- Authors
- Muzii, L., Galati, G., Di Tucci, C., Di Feliciantonio, M., Perniola, G., Di Donato, V., Benedetti Panici, P., & Vignali, M.
- Affiliations
- Sapienza University of Rome (IT)
- Department of Obstetrics and Gynecology, “Sapienza” University of Rome, Rome, Italy;
- University of Milan (IT)
- Corresponding author
- Muzii, Ludovico
- Venue
- Gynecological Endocrinology
- Publisher
- Informa UK Limited
- Published
- 2019-07-14
- Volume
- 36
- Issue
- 1
- Pages
- 81-83
- ISSN
- 0951-3590 (ISSN-L)
- 1473-0766
- OpenAlex
- W2959862727
- Cited by
- 55
- References
- 17
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 14 · 2023: 10 · 2022: 7 · 2021: 10 · 2020: 3
- FWCI
- 4.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gynecological Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
- Keywords
- endometrioma, dienogest, medical treatment, ovarian reserve, antral follicle count, anti-Müllerian hormone, cyst diameter, pelvic pain, GnRH agonist
- MeSH terms
- Adult, Endometriosis, Female, Ovarian Follicle, Hormone Antagonists, Humans, Nandrolone, Ovarian Diseases, Pain Measurement, Ultrasonography, Treatment Outcome, Pelvic Pain, Anti-Mullerian Hormone, Ovarian Reserve
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Medical treatment of ovarian endometriomas: a prospective evaluation of the effect of dienogest on ovarian reserve, cyst diameter, and associated pain. https://app.cochat.ai/papers/10.1080/09513590.2019.1640199
- The paper
- Muzii, L., Galati, G., Di Tucci, C., Di Feliciantonio, M., Perniola, G., Di Donato, V., Benedetti Panici, P., & Vignali, M. (2020). Medical treatment of ovarian endometriomas: a prospective evaluation of the effect of dienogest on ovarian reserve, cyst diameter, and associated pain. Gynecological Endocrinology. https://doi.org/10.1080/09513590.2019.1640199
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.